Blish CA - Search Results

1

Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung.

Wu TT, Travaglini KJ, Rustagi A, Xu D, Zhang Y, Andronov L, Jang S, Gillich A, Dehghannasiri R, Martínez-Colón GJ, Beck A, Liu DD, Wilk AJ, Morri M, Trope WL, Bierman R, Weissman IL, Shrager JB, Quake SR, Kuo CS, Salzman J, Moerner WE, Kim PS, Blish CA, Krasnow MA. Wu TT, et al. Among authors: blish ca. J Exp Med. 2024 Jun 3;221(6):e20232192. doi: 10.1084/jem.20232192. Epub 2024 Apr 10. J Exp Med. 2024. PMID: 38597954 Free PMC article.

2

The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection.

Lynch JB, Nduati R, Blish CA, Richardson BA, Mabuka JM, Jalalian-Lechak Z, John-Stewart G, Overbaugh J. Lynch JB, et al. Among authors: blish ca. J Virol. 2011 Jun;85(11):5252-61. doi: 10.1128/JVI.02216-10. Epub 2011 Mar 16. J Virol. 2011. PMID: 21411521 Free PMC article.

3

Transmission of HIV-1 in the face of neutralizing antibodies.

Blish CA, Blay WM, Haigwood NL, Overbaugh J. Blish CA, et al. Curr HIV Res. 2007 Nov;5(6):578-87. doi: 10.2174/157016207782418461. Curr HIV Res. 2007. PMID: 18045114 Review.

4

Loss of cell cycle controls in apoptotic lymphoblasts of the bursa of Fabricius.

Neiman PE, Blish C, Heydt C, Loring G, Thomas SJ. Neiman PE, et al. Mol Biol Cell. 1994 Jul;5(7):763-72. doi: 10.1091/mbc.5.7.763. Mol Biol Cell. 1994. PMID: 7812045 Free PMC article.

5

Hormonal contraception and HIV-1 transmission.

Blish CA, Baeten JM. Blish CA, et al. Am J Reprod Immunol. 2011 Mar;65(3):302-7. doi: 10.1111/j.1600-0897.2010.00930.x. Epub 2010 Nov 19. Am J Reprod Immunol. 2011. PMID: 21087338 Free PMC article. Review.

6

Enhanced natural killer-cell and T-cell responses to influenza A virus during pregnancy.

Kay AW, Fukuyama J, Aziz N, Dekker CL, Mackey S, Swan GE, Davis MM, Holmes S, Blish CA. Kay AW, et al. Among authors: blish ca. Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14506-11. doi: 10.1073/pnas.1416569111. Epub 2014 Sep 22. Proc Natl Acad Sci U S A. 2014. PMID: 25246558 Free PMC article.

7

Comparative immunogenicity of subtype a Human Immunodeficiency Virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopes.

Blish CA, Sather DN, Sellhorn G, Stamatatos L, Sun Y, Srivastava I, Barnett SW, Cleveland B, Overbaugh J, Hu SL. Blish CA, et al. J Virol. 2010 Mar;84(5):2573-84. doi: 10.1128/JVI.01687-09. Epub 2009 Dec 16. J Virol. 2010. PMID: 20015987 Free PMC article.

8

Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression.

Piantadosi A, Panteleeff D, Blish CA, Baeten JM, Jaoko W, McClelland RS, Overbaugh J. Piantadosi A, et al. Among authors: blish ca. J Virol. 2009 Oct;83(19):10269-74. doi: 10.1128/JVI.01149-09. Epub 2009 Jul 29. J Virol. 2009. PMID: 19640996 Free PMC article.

9

Chronic modulation of the TCR repertoire in the lymphoid periphery.

Blish CA, Gallay BJ, Turk GL, Kline KM, Wheat W, Fink PJ. Blish CA, et al. J Immunol. 1999 Mar 15;162(6):3131-40. J Immunol. 1999. PMID: 10092762

10

Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.

Blish CA, Dogan OC, Derby NR, Nguyen MA, Chohan B, Richardson BA, Overbaugh J. Blish CA, et al. J Virol. 2008 Dec;82(24):12094-103. doi: 10.1128/JVI.01730-08. Epub 2008 Oct 8. J Virol. 2008. PMID: 18842728 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page